California SB 17 Signed Into Law
Bill fails to recognize business model of generic industry.
AAM Statement on Federal District Court Ruling on HB 631
WASHINGTON, DC (September 29, 2017) – The Association for Accessible Medicines (AAM) is disappointed with the district court’s decision not to enjoin Maryland’s price gouging statute, which even the district court recognized may be unconstitutionally vague. As AAM has stated from the outset, this law will hurt patient access to safe, affordable generic medicines in Maryland and the rest of the U.S. and will create untenable uncertainty for generic drug makers who may be left with no choice but to abandon markets altogether.
Take Action on SB 17 to Protect Patient Access and Savings for Californians
Generic drugs have been lowering health care costs in California for decades, saving California $21.7 billion in 2016 alone. In fact, generics make up 89 percent of all prescriptions administered, yet account for only 26 percent of total drug costs.
Poll Results: California Proposed Drug Pricing Law (SB 17)
The key findings outlined in this report were drawn from a telephone survey of 1,023 California adults conducted August 4-9, 2017. A complete description of the methodology and demographics of the sample are at the end of this summary.
Poll: Majority of Californians are Unwilling to Support Proposed Drug Pricing Law
Without accounting for the critical role generic drugs play in reducing health care costs, SB17 would lead to increased prescription prices and limited access for patients
SACRAMENTO, CA (August 22, 2017) – While Californians share the rest of the country’s concern about rising health care costs, they are not willing to support proposed pricing legislation in the state because it will lead to increases in the cost of generic drugs, disproportionally affect the most vulnerable patients, and could limit patients’ access to generic medications.
How Much Did Generics Save You and Your State in 2016?
Michelle, a retired university librarian, is making the most of her golden years, taking vacations whenever she can. Saving money on her prescription drugs helps to put these adventures within reach for her.
“I have a very good relationship with my pharmacist,” she explains. “He said, ‘Don’t waste your money on the brand names.’ I’m on a fixed income, and those savings really do add up.”
US Generic Savings Map - 2016
Explore the interactive map
AAM Requests Federal Injunction to Block Maryland’s Unconstitutional Drug Price Law
Generic Pharmaceutical Trade Group Steps in to Protect Patient Access To Affordable Generic Drugs
Veto Maryland House Bill 631, Which Would Harm Patients by Chilling Generic Drug Competition
Everyone supports proposals to control rising prescription drug prices, but H.B. 631 would just make the problem worse for Maryland patients and our economy.
Protect Generic Drug Savings for Maryland Patients and Taxpayers
Governor Hogan Should Veto Legislation To Keep Generic Drugs Affordable for Maryland
WASHINGTON, DC (April 10, 2017) Generic drugs have been and continue to be an amazing success story in our healthcare system.